KR860000153B1 - Preparing process of cholesterol oxidase from the microorganism(kctc 8176 p) - Google Patents
Preparing process of cholesterol oxidase from the microorganism(kctc 8176 p) Download PDFInfo
- Publication number
- KR860000153B1 KR860000153B1 KR1019830002394A KR830002394A KR860000153B1 KR 860000153 B1 KR860000153 B1 KR 860000153B1 KR 1019830002394 A KR1019830002394 A KR 1019830002394A KR 830002394 A KR830002394 A KR 830002394A KR 860000153 B1 KR860000153 B1 KR 860000153B1
- Authority
- KR
- South Korea
- Prior art keywords
- enzyme
- cholesterol oxidase
- streptomyces
- cholesterol
- medium
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
제1도 : 스트렙토마이세스 에스피 NO. K-02(Streptomyces sp. NRRL NO. K-02 15218) : KCTC8176P)의 270배로 확대한 효모즙-맥아즙 한천배지.Figure 1: Streptomyces sp. NO. K-02 (Streptomyces sp. NRRL NO. K-02 15218): Yeast juice-wort agar medium at 270 times magnification of KCTC8176P).
제2도 : 스트렙토마이세스 에스피 NO. K-02(Streptomyces sp. NRRL NO. K-02 15218 : KCTC 8176P)의 270배로 확대한 오트밀 한천 배지.Figure 2: Streptomyces sp NO. Oatmeal agar medium magnified 270 times of K-02 (Streptomyces sp. NRRL NO. K-02 15218: KCTC 8176P).
제3도 : 스트렙토마이세스 에스피 NO. K-02(Streptomyces sp. NRRL NO. K-02 15218 : KCTC 8176P)의 270배로 확대한 전분한천배지.Figure 3: Streptomyces sp. NO. Starch agar medium at 270 times larger than K-02 (Streptomyces sp. NRRL NO. K-02 15218: KCTC 8176P).
제4도 : 스트렙토 마이세스 에스피 NO. K-02(Streptomyces sp. NRRL NO. K-02 15218 : KCTC 8176P)의 270배로 확대한 글리세린-아스파라긴 한천배지.Figure 4: Streptomyces sp. NO. Glycerine-asparagine agar medium at 270 times larger than K-02 (Streptomyces sp. NRRL NO. K-02 15218: KCTC 8176P).
제5도 : 스트렙토 마이세스 에스피 NO. K-02(Streptomyces sp. NRRL NO. K-02 15218 : KCTC 8176P) 균사의 20,000배로 확대한 포자의 형태.Figure 5: Streptomyses sp. NO. K-02 (Streptomyces sp. NRRL NO. K-02 15218: KCTC 8176P) Spore morphology magnified 20,000 times.
본 발명은 콜레스테롤 산화효소의 새로운 제조방법에 관한 것으로 미생물 균주 스트렙토마이세스 에스피 NO. K-02(Streptomyces sp. NRRL NO. K-02 15218 : KCTC 8176P)를 당질, 질소원 및 무기질을 함유하는 통상의 영양배지에 배양하여 콜레스테롤 산화효소를 제조하는 새롭고도 진보된 제조방법에 관한 것이다.The present invention relates to a novel method for preparing cholesterol oxidase and microbial strain Streptomyces sp. A new and advanced process for producing cholesterol oxidase by culturing K-02 (Streptomyces sp. NRRL NO. K-02 15218: KCTC 8176P) in conventional nutrient media containing carbohydrates, nitrogen sources and minerals.
콜레스테롤 산화효소는 콜레스테롤의 분해하여 콜레스테논과 과산화수소가 생성될 때에 이 반응을 촉진시키는 촉매효소 역활을 한다. 때문에 콜레스테롤의 효소적 정량방법에 널리 사용된다. 콜레스테롤 산화효소는 병리검사에서 혈중의 콜레스테롤 함량의 측정에 응용되고 있는바, 고혈압 및 심장질환 등의 질병 진단을 위한 수단으로 종래의 화학적 정색반응보다 신속하고도 정확한 측정법으로 활용되고 있다.Cholesterol oxidase acts as a catalytic enzyme to accelerate this reaction when cholesterol is broken down to produce cholesterol and hydrogen peroxide. Therefore, it is widely used in the enzymatic quantification method of cholesterol. Cholesterol oxidase has been applied to the measurement of cholesterol content in the blood in the pathology test, as a means for diagnosing diseases such as hypertension and heart disease is used as a faster and more accurate measurement method than the conventional chemical color reaction.
콜레스테롤 산화효소는 콜레스테롤 분해능을 가진 토양 미생물들이 발견되어 이들 미생물로부터 순도가 매우 높은 임사용 효소의 제조방법이 알려져 현재 노카르디아속, 마이코박테리움(Mycobacterium)속 스트렙토마이세스속 및 브레비박테리움(Brevibacterium)속 등의 균주를 영양 배지에 배양하여 균체 또는 배양액으로부터 콜레스테롤 산화효소를 생산하고 있으나, 그 수율은 균종에 따라 차이가 많고, 또 효소 활성이 낮기 때문에 정제효소제는 극히 고가로 판매되어 임상용 효소제의 응용과 보급에 커다란 애로점이 되고 있다. 예를들어 미국특허 4,144,129(1979.3.13)에 의하면 미생물 균주 프로악티노미세스 에리트로폴리스(Proactinomyces erythroplois ATCC17895)를 영양배지에 접종하고 효소 유도물질로 콜레스테롤 현탁액을 첨가하여 통기 배양하면 효소수율이 배지 1리터당 건조균체 7그람과 효소 활성 약 280단위를 얻었다고 한다. 일본공개 특허공보 54-76893(1979.6.19)에 의하면 균주 스트렙토마이세스 바이오리센스, H82N-SV7(Streptomyces violascense)를 영양배지에 접종하고 27℃에서 96시간 배양하여 효소수율이 배지 1리터당 813단위를 얻었다고 하였다.Cholesterol oxidase has been found in soil microorganisms with cholesterol degrading ability to produce a high purity forest enzyme from these microorganisms is currently known as genus Nocardia, Mycobacterium genus Streptomyces genus and Brevibacte Cholesterol oxidase is produced from cells or cultures by culturing strains of the genus Brevibacterium, etc., but the yields vary widely depending on the species and the enzyme activity is low. The application and dissemination of clinical enzymes has become a major obstacle. For example, according to US Patent 4,144,129 (1979.3.13), the microbial strain Proactinomyces erythroplois ATCC17895 is inoculated into a nutrient medium and aerated by adding a cholesterol suspension as an enzyme-inducing substance to dry the enzyme yield per 1 liter of medium. Seven grams of cells and about 280 units of enzyme activity were obtained. According to Japanese Laid-Open Patent Publication 54-76893 (Jun. 9, 1979), strain Streptomyces biosense, H82N-SV7 (Streptomyces violascense) was inoculated into a nutrient medium and incubated at 27 ° C for 96 hours to obtain an enzyme yield of 813 units per liter of medium. Was obtained.
이와같이 종래의 미생물 유래의 콜레스테롤 산화효소생산방법은 미생물 균체내로부터 또는 균체외로 부터 효소를 추출정제하는 통상의 정제방법에 따라 생산하였다. 전자의 균주는 주로 노카르디아(Nocardia)속 균주이며 후자의 균주는 스트렙토 마이세스(Streptomyces)와 브리비박테리움(Brevibacterium)속 균주로 알려져 있고, 이들 균주를 탄소원으로 콜레스테롤을 함유한 영양배지에서 배양한 결과 수율이 높은 효소활성을 얻었다고 한다.As described above, a conventional method for producing cholesterol oxidase derived from microorganisms has been produced according to a conventional purification method for extracting and purifying enzymes from microorganism cells or from cells. The former strains are mainly Nocardia strains and the latter strains are known as Streptomyces and Brevibacterium strains. It was reported that a high yield of enzyme activity was obtained by culturing.
본 발명자들은 콜레스테롤 산화효소의 공업적 생산을 목적으로 임상효소제의 응용을 위한 경제성이 매우 높은 우수한 콜레스테롤 산화효소를 생산하는 미생물 검색을 시도하였다. 즉, 국내 각지역의 토양을 체취하여 스트렙토마이세스속 균주를 분리하고 포도당을 탄소원으로 하는 통상의 합성영양배지에 배양한 결과 배지로부터 콜레스테롤 분해능이 예상외로 극히 높은 효소 생산스트렙토 마이세스 에스피 NO. K-02(Streptomyces sp. NRRL NO. 15218 : KCTC 8176P)를 분리하였다.The present inventors have attempted to search for microorganisms that produce excellent cholesterol oxidase having a very high economic efficiency for the application of clinical enzymes for the purpose of industrial production of cholesterol oxidase. In other words, by separating the soil of each region in Korea, strains of the genus Streptomyces were isolated, and cultured in a conventional synthetic nutrient medium containing glucose as a carbon source. K-02 (Streptomyces sp. NRRL NO. 15218: KCTC 8176P) was isolated.
이 균주는 포도당을 탄소원으로 하는 합성배지에서 통상의 배양방법에 따라 배양한 결과 효소수율은 배지 1미리리터당 8단위와 높은 활성을 나타내었는데 이것은 종래의 효소 수율보다 약 10배가 더높은 극히 우수한 균주이며 효소 유도물질로 배지조성중에 콜레스테롤이 필요없는 것이 특징이다. 본 균주에 의한 콜레스테로 산화효소의 생성은 배지중에 콜레스테롤 분해능을 가진 효소가 균체외로 용이하게 분비됨으로 노카르디아속의 균주와 같이 균체를 파괴하여 효소를 추출할 필요없이 배양액으로부터 직접효소르 회수할 수 있는것이 대표적인 장점이다.This strain was cultured in a synthetic medium using glucose as a carbon source, and the enzyme yield was 8 units per 1 milliliter of medium, and the activity was high, which was about 10 times higher than the conventional enzyme yield. It is an enzyme-inducing substance characterized by no need for cholesterol in the medium composition. The production of cholesterol oxidase by this strain is easy to secrete enzymes having cholesterol degrading ability in the medium, so that the enzymes can be recovered directly from the culture without destroying the bacteria and extracting the enzymes like the strains of the genus Nocardia. It is a representative advantage.
본 발명에 따라 생산된 정제효소는 통상의 콜레스테롤 정량법에 응용할 수 있는 임상용효소제로 사용할 수 있다. 즉, 콜레스테롤의 반응을 촉매해주는 효소는 다음의 반응식으로 표시되며,The purified enzyme produced according to the present invention can be used as a clinical enzyme for application in conventional cholesterol assay. In other words, the enzyme catalyzing the reaction of cholesterol is represented by the following reaction,
콜레스테롤+산소………→콜레스테논+과산화수소 콜레스테롤산화효소Cholesterol + Oxygen … … → cholesterone + hydrogen peroxide cholesterol oxidase
이 효소는 산소의 존재하에 반응하는 산화환원 효소로 반응생성물로는 과산화수소를 생성한다. 따라서 효소활성은 반응중에 생성된 과산화수소의 양을 측정함으로써 용이하게 측정된다. 본 발명의 미생물 효소는 콜레스테롤 만을분해하고 기타 다른 스테롤은 분해하지 않는 특이성을 가지므로 콜레스테롤 산화효소라 확인되었다.This enzyme is a redox enzyme that reacts in the presence of oxygen to produce hydrogen peroxide as a reaction product. Therefore, enzyme activity is easily measured by measuring the amount of hydrogen peroxide produced during the reaction. The microbial enzyme of the present invention has been identified as cholesterol oxidase because it has the specificity of degrading cholesterol only and not degrading other sterols.
콜레스테롤 산화효소의 효소활성 측정법은 과산화 효소와 오르토다아니시딘(orhto-dianisidine)을 사용한 복합 효소적 측정법을 사용하여 온도 37℃에서 1분당 1미크로물의 과산화수소를 생성하는 효소의 양을 효소 1단위로 하였다.Determination of the enzyme activity of cholesterol oxidase using a complex enzymatic assay using peroxidase and orhto-dianisidine, one enzyme per unit of enzyme that produces 1 micron of hydrogen peroxide per minute at 37 ° C It was.
본 발명의 실시내용은 콜레스테롤 산화효소의 생산능을 가진 스트렙토마이세스 에스피 K-02(NRRL NO. 15218 : KCTC 8176P)를 통상의 합성배지, 예를들면 포도당 5.0%, 황산암모늄 0.2%, 염화칼슘 0.001%, 황산 제1철 0.001%, 제1인산카리 0.2%, 황산마그네슘 0.02%와 효모엑기스 2.0% 및 중성의 PH에서 액체 배지에 배양하여 배지중의 효소활성을 축적시키고, 배양종료 후 배양액을 직접 회수하여 조효소를 만들어 통상의 생화학 효소 정제방법에 따라 수율이 극히 높은 정제효소를 용이하게 회수하는 콜레스테롤 산화효소의 제법에 관한 것이다.Embodiments of the present invention are directed to Streptomyces sp. K-02 (NRRL NO. 15218: KCTC 8176P), which has the ability to produce cholesterol oxidase, to conventional synthetic media, such as glucose 5.0%, ammonium sulfate 0.2%, and calcium chloride 0.001. %, Ferrous sulfate 0.001%, ferric phosphate 0.2%, magnesium sulfate 0.02%, yeast extract 2.0% and neutral pH in liquid medium to accumulate enzymatic activity in the medium, and after completion of culture The present invention relates to a method for preparing cholesterol oxidase that recovers crude enzyme to easily recover purified enzyme having a high yield according to a conventional biochemical enzyme purification method.
본 발명자들이 분리한 스트렙토 마이세스 에스피 K-02(NRRL NO. 15218 : KCTC 8176P)의 균학적 성질은 다음과 같으며, 이를 기지의 동정방법(International Streptonyces Project)에 따라 분리동정하였다.The microbial properties of Streptomyces sp K-02 (NRRL NO. 15218: KCTC 8176P) isolated by the present inventors were as follows, which were isolated and identified according to the known international Streptonyces Project.
가. 형태적 성질(제5도 참조)end. Morphological Properties (See Figure 5)
1. 기균사 : 회뱃개 분생자의 기균사, 나선형이 없고 선형임.1.Bacillus mycelia: Bacillus mycelia, linear, without spiral.
2. 포자형태와 크기 : 0.6-0.8(μ)×1.0-1.5(μ), 표면이 평활2. Spore type and size: 0.6-0.8 (μ) × 1.0-1.5 (μ), surface is smooth
3. 운동성 : 없음3. Mobility: None
4. 그람염색 : 양성4. Gram Dyeing: Positive
나. 배양적 성질I. Culture properties
1) 수용성 색소는 0.05N NaOH, 0.05N, HCI첨가시에도 불변1) Water-soluble pigment is unchanged even when adding 0.05N NaOH, 0.05N, HCI
2) 27℃에서 13일간 연속 배양후 관찰2) Observation after continuous incubation for 13 days at 27 ℃
다. 생리적 성질All. Physiological properties
1) 생육온도범위 : 25-37℃1) Growth temperature range: 25-37 ℃
2) 최적생육 온도범위 : 30-35%2) Optimal growth temperature range: 30-35%
3) 생육 PH범위 : 4.0-9.53) Growth PH Range: 4.0-9.5
4) 최적생육 pH범위 : 6.0-8.04) Optimal growth pH range: 6.0-8.0
5) 산소요구성 : 호기성5) Oxygen Requirements: Aerobic
6) 사멸온도 : 60℃6) Death temperature: 60 ℃
7)리트머스밀크 : 불변7) litmus milk: unchanged
8) 카탈라제생산 : 양성8) Catalase Production: Positive
9)젤라딘 액화력 : 양성9) Geladin Liquefaction: Positive
10) 전분분해력 : 양성10) starch resolution: positive
11) 멜라노이드 색소 생산 : 양성11) Melanoid Pigment Production: Positive
12) 탄소원의 이용성 :12) Availability of Carbon Sources:
*27℃에서 11일간 배양후 관찰한 결과임.* Observed after 11 days incubation at 27 ℃.
본 발명의 분리균종을 상기 동정방법에 따라 집락의 특징 형태적 특징 및 생리적 특징등을 조사한 결과 본 균종은 스트렙토마이세스소게 속하는 균주하고 판단되었다.As a result of examining the morphological characteristics and physiological characteristics of colonies according to the identification method of the isolated species of the present invention, it was determined that the strain belonged to Streptomyces soge.
본 발명의 스트렙토 마이세스 K-02(NRRL NO. 15218 : KCTC 8176P) 균주를 실시예의 실험에서와같이 포도당과 효모엑기스를 주영양원으로하는 통상의 영양배지에 접종하고, 통상의 통기배양 최적조건에서 배양하면 효소활성이 극히 높은 콜레스테롤산화 효소가 배지중에 유도된다. 배지중의 균체를 완전히 제거한 다음 생화학적 효소정제 방법에 따라 조효소를 정제하면 수율이 극히 높은 정제효소를 용이하게 얻을 수 있다.Streptomyces K-02 (NRRL NO. 15218: KCTC 8176P) strains of the present invention were inoculated into a conventional nutrient medium containing glucose and yeast extract as a main nutrient source, as in the experiments of the examples, and under normal aeration culture conditions. When cultured, cholesterol oxidase having extremely high enzyme activity is induced in the medium. After completely removing the cells in the medium and purifying the crude enzyme according to the biochemical enzyme purification method can be easily obtained purified enzyme with a very high yield.
본 발명의 실시효과를 상세히 설명한 실시예는 다음과 같으며 본 발명의 범위가 이에 국한된다는 것은 아니다.The embodiments described in detail the embodiments of the present invention are as follows, but the scope of the present invention is not limited thereto.
[실시예 1]Example 1
스트렙토마이세스 에스피 K-02(NRRL NO. 15218 : KCTC 8176P) 백금 이를 50mml의 배지(5% 포도당, 0.2% 황산암모늄 0.001% 염화칼슘, 0.001% 황산 제2철, 0.2% 제1인산카리, 0.02% 황산마그네슘, 2%효소엑기스)에 접종하여 30℃에서 3일간 진탕 배양한 후, 이중 5ml를 종모액으로 사용하여 같은 배지 100ml에 접종하고 30℃에서 18시간 진탕 배양하였다.Streptomyces sp K-02 (NRRL NO. 15218: KCTC 8176P) Platinum 50 mg of this medium (5% glucose, 0.2% ammonium sulfate 0.001% calcium chloride, 0.001% ferric sulfate, 0.2% carry monophosphate, 0.02% Magnesium sulfate, 2% enzyme extract) was incubated for 3 days at 30 ℃ shaking culture, 5 ml of this was used as seed stock inoculated in 100 ml of the same medium and cultured shaking at 30 ℃ 18 hours.
효소활성 측정은 3ml의 반응혼합 기질용액(0.1몰 인산 완충액, PH 7.0, 2.5ml, 0.01몰 오트소-디아니시딘 0.1, 0.1ml 과산화효소액)에 0.05ml의 효소액을 혼합한 후 분광광도계의 파장 460nm에서 흡광도의 1분당 반응율을 측정하는 통상의 효소 측정방법을 사용하였다. 효소 1단위는 37℃에서 1미크로몰의 과산화수소를 생성하는 효소의 양을 1단위로 하였다. 효소측정 결과는 균체를 제거한 배양액 1ml당 2-5단위로서 총 200-500단위를 생산하였다.Enzyme activity was measured by mixing 0.05 ml of enzyme solution in 3 ml of reaction mixture substrate solution (0.1 mole phosphate buffer, PH 7.0, 2.5 ml, 0.01 mole Otso-Dianisidine 0.1, 0.1 ml peroxide enzyme solution) and then A conventional enzyme measuring method of measuring the reaction rate per minute of absorbance at 460 nm was used. One unit of the enzyme was 1 unit of the amount of the enzyme that produces 1 micromolar hydrogen peroxide at 37 ° C. The enzyme measurement result was 2-5 units per ml of the culture medium from which the cells were removed, producing a total of 200-500 units.
[실시예 2]Example 2
스트렙토마이세스 에스피 K-02(NRRL NO. K-02 15218 : KCTC 8176P)의 종모액 5ml를 실시예 1의 배지 100ml에 접종한 후 30℃에 진탕 배양하고 배양시간에 따른 효소생산량을 측정한 결과는 다음과 같다.5 ml of Streptomyces sp. K-02 (NRRL NO. K-02 15218: KCTC 8176P) was inoculated into 100 ml of Example 1 medium, followed by shaking culture at 30 ° C., and the production of enzyme according to incubation time. Is as follows.
배양시간 24시간후의 효소역가는 배지 100ml당 300단위였고, 배양시간이 경과하메 따라 점차 증가하여 약 48시간후에는 100ml당 500단위로 최고치에 달하였다.The enzyme titer after 24 hours incubation time was 300 units per 100 ml of medium, and gradually increased as the culture time elapsed, reaching a maximum of 500 units per 100 ml after about 48 hours.
상기 균주배양액을 원심분리하여 균체를 제거한 다음 배양액을 콜레스테롤 산화효소의 조효소액으로 사용하였다.The strain culture medium was centrifuged to remove the cells, and then the culture medium was used as the coenzyme solution of cholesterol oxidase.
[실시예 3]Example 3
스트렙토마이세스에스피 K-02(NRRL NO. K-02 15218 : KCTC8176P)의 종모액 100ml를 실시예 1의 배지 400ml에 접종하고 500ml용 통기발효조에서 온도 30℃, 통기량 1.5VVM, 회전수 300rpm하에 약 48시간 배양한 결과 효소생산량은 배양액 1ml당 5단위로 총 20.000단위의 조효소액을 생산하였다.100 ml of Streptomyces sp. K-02 (NRRL NO. K-02 15218: KCTC8176P) was inoculated into 400 ml of the medium of Example 1, and then in a 500 ml aeration fermenter at a temperature of 30 ° C., aeration rate of 1.5 VVM, and rotation speed of 300 rpm. As a result of incubation for about 48 hours, the enzyme production amount was 5 units per 1 ml of culture, which produced a total of 20.000 units of crude enzyme solution.
[실시예 4]Example 4
실시예 3의 종모액 500ml를 동일한 영양배지 15l에 접종하고 28l용 통기발효조에서 배양온도 30℃, 통기량 1.5VVM, 회전수 300rpm하에 약 48시간 배양한 결과 효소 생산량은 배양액 1ml 8단위로 총 160,000단위의 조효소액을 생산하였다. 균체를 완전히 제거한 조효소액을 생화학적 효소정제방법에 따라 효소를 졍제한 결과 단백질 미리그람당 15-20단위의 고순도 정제효소를 생산할 수 있었다.Inoculated with 500 ml of the seedling solution of Example 3 in 15 l of the same nutrient medium and incubated in a 28-l aeration fermenter for about 48 hours at a culture temperature of 30 ° C., an aeration rate of 1.5 VVM, and a rotation speed of 300 rpm, the total enzyme production was 160,000 units of 8 ml of culture medium A unit of crude enzyme solution was produced. As a result of removing the enzyme from the crude enzyme solution completely removed from the cells according to the biochemical enzyme purification method, it was possible to produce 15-20 units of purified enzyme per gram of protein.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019830002394A KR860000153B1 (en) | 1983-05-31 | 1983-05-31 | Preparing process of cholesterol oxidase from the microorganism(kctc 8176 p) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019830002394A KR860000153B1 (en) | 1983-05-31 | 1983-05-31 | Preparing process of cholesterol oxidase from the microorganism(kctc 8176 p) |
Publications (2)
Publication Number | Publication Date |
---|---|
KR840008814A KR840008814A (en) | 1984-12-19 |
KR860000153B1 true KR860000153B1 (en) | 1986-02-27 |
Family
ID=19229057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019830002394A KR860000153B1 (en) | 1983-05-31 | 1983-05-31 | Preparing process of cholesterol oxidase from the microorganism(kctc 8176 p) |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR860000153B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100464674B1 (en) * | 2002-08-27 | 2005-01-03 | 학교법인 계명기독학원 | A method for producing cholesterol oxidase from Streptomyces sp. |
-
1983
- 1983-05-31 KR KR1019830002394A patent/KR860000153B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR840008814A (en) | 1984-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS61104784A (en) | Production of peroxidase | |
EP0188316A2 (en) | Process for the preparation of amides using microorganisms | |
US4774179A (en) | Process for preparing a 7-aminocephalosporanic acid compound | |
EP0468411B1 (en) | A mutant of bacterium Clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase | |
US4387163A (en) | Process for producing the enzyme cholesterol esterase and for hydrolyzing cholesterol esters of fatty acids by using the enzyme itself | |
JP2840722B2 (en) | Method for producing 4-halo-3-hydroxybutyronitrile | |
US5238827A (en) | Process for preparing glycine from glycinonitrile | |
US4740465A (en) | Heat-resistant sarcosine oxidase N and process for producing the same | |
KR860000153B1 (en) | Preparing process of cholesterol oxidase from the microorganism(kctc 8176 p) | |
JPH07170979A (en) | New creatine amidinohydrolase and its production | |
US3767533A (en) | Process for producing uricase | |
JPS6143037B2 (en) | ||
EP0206595B1 (en) | Thermally stable tryptophanase process for producing the same, and thermally stable tryptophanase-producing microorganism | |
JPH01148192A (en) | Production of carnitine | |
JP3782621B2 (en) | Histamine dehydrogenase and process for producing the same | |
JPH0249720B2 (en) | ||
JPH05211868A (en) | Production of alkali protease | |
JP2800005B2 (en) | Method for producing deoxyribonucleic acid | |
JP3957053B2 (en) | Novel microorganism and method for producing pravastatin | |
JPH07227276A (en) | Lipase, microorganism producing the same lipase and method for obtaining the same microorganism | |
JPH0127714B2 (en) | ||
JP3743172B2 (en) | Method for producing L-homocysteine | |
JPS60995B2 (en) | New method for producing 7-amino-cephalosporanic acid and its derivatives | |
JP3173176B2 (en) | Method for producing S (+)-citramalic acid | |
JP3413294B2 (en) | Method for producing 2,5-dihydroxypyridine and bacteria producing 2,5-dihydroxypyridine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 19880212 Year of fee payment: 12 |
|
LAPS | Lapse due to unpaid annual fee |